Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TUSC2 pseudogene 2 (TUSC2P2) is classified as a pseudogene, meaning it is a DNA sequence resembling the gene for the protein tumor suppressor candidate 2 (TUSC2) but does not encode a functional protein. Pseudogenes like TUSC2P2 can have regulatory functions at the RNA level. TUSC2P2 and related pseudogene transcripts are known to act as *competing endogenous RNAs (ceRNAs)* that sequester microRNAs (miRNAs), thereby modulating the translation of TUSC2 and other genes involved in tumor suppression. While TUSC2P2 shows altered expression in normal versus cancer cells and may regulate tumor suppressor pathways indirectly, it is not itself considered a therapeutic target, receptor, enzyme, transporter, or drug-binding molecule. There is no evidence for direct drug interactions or use as a clinical biomarker. TUSC2 (the protein-coding gene) is a well-known tumor suppressor involved in apoptosis, cell proliferation, and mitochondrial regulation, but TUSC2P2 is a non-functional pseudogene with potential regulatory effects only through miRNA binding and does not encode a protein or receptor. This information is specific to TUSC2P2; misspellings or confusion may arise due to the close similarity to TUSC2, but they refer to distinct genomic entities.
Not applicable for TUSC2P2; it functions through modulation of miRNA activity as non-coding RNA, not as a direct drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TUSC2 pseudogene 2 (TUSC2P2).